[5-ETA-C10H15(PME3)RH(SIPH3)(NC-TERT.-BUTYL)]-[B(3,5-C6H3(CF3)2)4]
Compound with spectra: 2 NMR
![[5-ETA-C10H15(PME3)RH(SIPH3)(NC-TERT.-BUTYL)]-[B(3,5-C6H3(CF3)2)4]](/api/compound/FPWsjP9p8v3.png?ph=true&h=300&w=458 "[5-ETA-C10H15(PME3)RH(SIPH3)(NC-TERT.-BUTYL)]-[B(3,5-C6H3(CF3)2)4]")
| SpectraBase Compound ID | FPWsjP9p8v3 |
|---|---|
| InChI | InChI=1S/C32H12BF24.C18H15Si.C10H15.C5H9N.C3H9P.Rh/c34-25(35,36)13-1-14(26(37,38)39)6-21(5-13)33(22-7-15(27(40,41)42)2-16(8-22)28(43,44)45,23-9-17(29(46,47)48)3-18(10-23)30(49,50)51)24-11-19(31(52,53)54)4-20(12-24)32(55,56)57;1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-6-7(2)9(4)10(5)8(6)3;1-5(2,3)4-6;1-4(2)3;/h1-12H;1-15H;1-5H3;1-3H3;1-3H3;/q-1;;;;;/p+1 |
| InChIKey | FUXCNVMLMLKECZ-UHFFFAOYSA-O |
| Mol Weight | 1521.0 g/mol |
| Molecular Formula | C68H61BF24NPRhSi |
| Exact Mass | 1520.307561 g/mol |
| Parent InChIKey | QOECVILPHHEFCW-UHFFFAOYSA-O |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD2Cl2 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD2Cl2 |
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
(1R,5R,7S,8S,9S,10R)-1-[(2R*,5S)-5-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2-methoxy-5-methyltetrahydrofuran-2-yl]-9-ethyl-8,10-isopropylidenedioxy-1-(4-methoxybenzyloxy)-5,7-dimethyldodeca-2-yn-4-one
6-(tert-Butyldimethylsiloxy)-3,4-(isopropylidenedioxy)-10,11-(di-tert-butylsilylnedioxy)-12,12-(2',2'-dimethylpropane-1',3'-diyldioxy)-2-oxo-1,2,3-(R*),4(R*)),4(S*),5,5a(S*),6(S*),11(R*),11a(R*),12,12a-(S*)-dodecahydronaphthacene
(2S,5S,7S,9S,10S,12R,13R*,14R*)-9-[(1S,2R*)-1-Ethyl-2-hydroxybutyl]-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydropyran-2-yl]-15-(4-methoxybenzyloxy)-2,10,12-trimethyl-1,6,8-trioxodispiro[4.1.5.3]pentadecan-13,14-diol
(1R,5R,7S,8S,9S,10R)-1-[(2R*,5S)-5-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2-methoxy-5-methyltetrahydrofuran-2-yl]-9-ethyl-8,10-isopropylidenedioxy-1-(4-methoxybenzyloxy)-5,7-dimethyldodeca-2-en-4-ol
(1a.alpha.,3a.alpha.,5a.alpha.6.alpha.,8.beta.,8a.alpha.,8b.beta.,10a.alpha.,10b.beta.,10c.alpha.)-Dodecahydro-10-[(2-methoxyethoxy)methoxy]-8-(methoxymethoxy)-6,8b-dimethyl-1H-naphth[2',1',8':3,4,5]azuleno[1.8-bc]furan-3,4(1aH,5H)-dione
(2S,5R,6R,10R,12S,13S,14S,15R)-2-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2,5-bis(tert-butyldimethylsilyloxy)-13,15-isopropylidenedioxy-6-(4-methoxybenzyloxy)-10,12-dimethylheptadec-7-yn-9-one1-yne
Quamoclin II peracetate[(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
2-Propenoic acid, 3-phenyl-, 1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-3a,6b-dihydroxy-1,1,5,7-tetramethyl-4-oxo-2a-[[(1-oxo-3-phenyl-2-propenyl)oxy]methyl]-8aH-cyclopropa[5',6']benz[1',2':7,8]az uleno[5,6-b]oxirene-8,8a-diyl ester, [1aR-(1a.alpha.,1b.beta.,1c.beta.,2a.beta.,3a.beta.,6a.alpha.,6b.alpha.,7.alpha.,8.beta.,8a.alpha.)]-
1-Pentamethylcyclopentadienyl-1-carbonyl-2-oxo-1-iridia-3,4,5,6-tetraphosphabicyclohexane-3,4,6-tri-chromium complexe
| Title | Journal or Book | Year |
|---|---|---|
| Carbon−Carbon Bond Activation of R−CN (R = Me, Ar, iPr, tBu) Using a Cationic Rh(III) Complex | Journal of the American Chemical Society | 2002 |